ARVN
$23.43
Arvinas
($.41)
(1.72%)
ARVN
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.79)
Revenue:  $7.46 Mil
Thursday
Feb 4
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARVN reports earnings?
Beat
Meet
Miss

Where is ARVN's stock price going from here?
Up
Flat
Down
Stock chart of ARVN
Analysts
Summary of analysts' recommendations for ARVN
Score
Grade
Pivots
Resistance
$24.35
$24.10
$23.77

$23.52

Support
$23.19
$22.94
$22.61
Tweet
Growth
Description
Arvinas Inc. is a biopharmaceutical company for patients suffering from debilitating and life-threatening diseases. It engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Arvinas Inc. is based in CT, United States.